Keywords
Obesity
Weight loss
Endoscopy
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the clinical and epidemiological profile of patients who underwent intragastric balloon (IGB) placement in a reference hospital in Northern Brazil between 2019 and 2024. Methods: Observational, retrospective, descriptive, and analytical study conducted through the review of electronic medical records in the Endoscopy Service of a hospital in Belém, Pará. Patients of both sexes, aged ≥18 years, with complete records and a minimum follow-up of six months were included. Sociodemographic, clinical, and anthropometric variables were analyzed using Microsoft® Excel® 2016 and BioEstat 5.4 software. Chi-square, G-test for goodness of fit, paired Student’s t-test, and Kruskal-Wallis tests were applied, with α = 0.05. Results: The sample comprised 73 patients, predominantly women (60.3%), with a mean age of 39.8 years. The mean weight loss was 19.2 kg (11.2%) with a significant reduction in BMI (p < 0.0001). Complications were rare, mainly nausea and abdominal pain. Multidisciplinary follow-up occurred in 97.3% of cases, primarily involving Nutrition, Psychology, and Endocrinology. Conclusion: The IGB proved to be safe and effective, with a low complication rate and clinically relevant weight loss outcomes, enhanced by adherence to multidisciplinary follow-up.
References
ABEID M, et al. Efficacy and safety of intragastric balloon placements in 1600 cases: an experience from the Middle East. Obes Surg, 2019; 29(7): 2087-2091.
BARRICHELLO S, et al. Gastric emptying and its correlation with weight loss and body mass index in patients with an intragastric balloon: a prospective study with six years of follow-up. Cureus, 2022; 14(12): e32599.
BAZERBACHI F, et al. Endoscopic bariatric therapy: a guide to the intragastric balloon. Am J Gastroenterol, 2019; 114(9): 1421-1431.
BORGES AC, et al. Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience. Rev Col Bras Cir, 2018; 45(1): e1448.
CANAZAS VMA, et al. Tendência temporal da obesidade em adultos usuários da atenção primária à saúde do Sistema Único de Saúde no período 2008-2023. Revista Observatorio de laEconomíaLatinoamericana, 2024; 22(7): 1-19.
DIAB AF, et al. The effect of age, gender, and baseline BMI on weight loss outcomes in obese patients undergoing intragastric balloon therapy. Obes Surg, 2019; 29(11): 3542-3546.
FRIO GS, et al. The disruption of elective procedures due to COVID-19 in Brazil in 2020. Sci Rep, 2022; 12(1): 10942.
GALVÃO NETO M, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg ObesRelat Dis, 2018; 14(2): 151-159.
JENSE MTF, et al. The swallowable intragastric balloon combined with lifestyle coaching: short-term results of a safe and effective weight loss treatment for people living with overweight and obesity. Obes Surg, 2023; 33(6): 1668-1675.
JEREZ J, et al. Intragastric balloon and impact on weight loss: experience in Quito, Ecuador. Arq Bras Cir Dig, 2023; 36: e1731.
KEREN D, RAINIS T. Intragastric balloons for overweight populations — one year post removal. ObesSurg, 2018; 28: 2368-2373.
KHAN MS, et al. A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity. Saudi J Gastroenterol, 2025; 31(2): 93-99.
MARRERO TORRES RJ, et al. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges. Surg Endosc, 2022; 36(7): 5160-5166.
MASUKO TM, et al. Cirurgia bariátrica e a pandemia do novo coronavírus: análise comparativa do impacto em procedimentos do SUS e de convênio. BioScience, 2023; 81(1): 17-20.
MIGOWSKI A, COSTA GTL. Análise temporal da prevalência da obesidade e do sobrepeso no Brasil entre 2006 e 2023: evidências a partir dos dados do Vigitel. OnScience, 2024; 2(1): e00104.
NUNES GC, SILVA LB. Nutritional follow-up during intragastric balloon treatment. In: GALVÃO NETO M, SILVA L, USUY JR E, CAMPOS J (eds). Intragastricballoon for weight management. Springer, Cham, 2020; p. 1-10.
PASCHOALOTTO MAC, et al. Regionalização da saúde no Brasil: desigualdades socioeconômicas e na performance em saúde. Gestão & Regionalidade, 2022; 38(113): 1-15.
PEREYRA-TALAMANTES A, et al. Benefits of multidisciplinary team management of obese patients with intragastric balloon placement: an analysis of 159 cases at a single center. Surg ObesRelat Dis, 2020; 16(12): 2068-2073.
PINHO AC, et al. Intragastric balloon as a first step before metabolic bariatric surgery in patients with BMI ≥ 50 kg/m²: are the results after balloon related to global outcomes after surgery? Obes Surg, 2024; 34(9): 3195-3202.
VARGAS EJ, et al. Effectiveness of online aftercare programs following intragastric balloon placement for obesity is similar to traditional follow-up: a large propensity matched US multicenter study. Obes Surg, 2019; 29: 4036-4042.
VIACAVA F, et al. Desigualdades regionais e sociais em saúde segundo inquéritos domiciliares (Brasil, 1998–2013). Ciência & Saúde Coletiva, 2019; 24(7): 2745–2760.
WIGGINS T, et al. Safety and efficacy of 12-month intra-gastric balloon: series of over 1100 patients. Obes Surg, 2024; 34(1): 176-182.